Lantern Pharma (LTRN) Tops Q3 EPS by 19c
Lantern Pharma (NASDAQ: LTRN) reported Q3 EPS of ($0.29), $0.19 better than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.
Lantern Pharma (NASDAQ: LTRN) reported Q3 EPS of ($0.29), $0.19 better than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.